|
Insider Trading: Haemonetics Corp
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Haemonetics Corp in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Haemonetics Corp since year 2005. Table 2 shows the detailed insider transactions of Haemonetics Corp since 2005.
The reporting company's ticker symbol is HAE.
The reporting company's CIK number is 313143.
The total value of stock buying since 2005 is $1,373,573.
The total value of stock sales is $29,022,507.
The total value of stock exercises is $12,658,087.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Haemonetics Corp (HAE) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at Haemonetics Corp (HAE) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Haemonetics Corp (HAE).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-07 | 0 | 0 | 50,000 | 2,750,000 | 50,000 | 1,095,500 |
| 2008-06 | 0 | 0 | 50,500 | 2,885,030 | 50,500 | 1,108,552 |
| 2008-05 | 6,199 | 291,564 | 50,775 | 2,795,586 | 50,000 | 1,095,500 |
| 2008-04 | 0 | 0 | 500 | 27,990 | 500 | 13,052 |
| 2008-03 | 0 | 0 | 623 | 36,578 | 400 | 10,442 |
| 2008-02 | 0 | 0 | 9,500 | 557,674 | 9,500 | 167,437 |
| 2008-01 | 0 | 0 | 10,000 | 619,800 | 10,000 | 288,825 |
| 2007-11 | 1,199 | 48,752 | 18,850 | 1,084,171 | 18,850 | 730,146 |
| 2007-07 | 0 | 0 | 7,000 | 369,504 | 7,000 | 159,031 |
| 2007-06 | 0 | 0 | 8,000 | 408,000 | 8,000 | 253,280 |
| 2007-05 | 3,517 | 135,865 | 10,452 | 522,357 | 10,000 | 242,350 |
| 2007-04 | 0 | 0 | 7,000 | 336,000 | 7,000 | 159,031 |
| 2007-02 | 0 | 0 | 38,183 | 1,797,345 | 38,183 | 781,222 |
| 2006-11 | 1,824 | 70,693 | 400 | 18,307 | 0 | 0 |
| 2006-09 | 0 | 0 | 59,694 | 2,715,163 | 59,694 | 1,698,612 |
| 2006-08 | 4,442 | 199,867 | 192,024 | 8,647,055 | 192,024 | 3,141,349 |
| 2006-07 | 0 | 0 | 400 | 18,682 | 0 | 0 |
| 2006-06 | 0 | 0 | 64,000 | 3,039,245 | 63,000 | 1,011,125 |
| 2006-05 | 2,347 | 97,449 | 0 | 0 | 0 | 0 |
| 2006-03 | 0 | 0 | 0 | 0 | 30,200 | 543,600 |
| 2006-02 | 2,110 | 104,972 | 7,000 | 351,400 | 7,000 | 159,033 |
| 2005-11 | 6,203 | 301,610 | 0 | 0 | 0 | 0 |
| 2005-09 | 1,000 | 44,710 | 0 | 0 | 0 | 0 |
| 2005-05 | 3,290 | 78,091 | 0 | 0 | 0 | 0 |
| 2005-04 | 0 | 0 | 400 | 30,800 | 0 | 0 |
| 2004-04 | 0 | 0 | 400 | 11,820 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Haemonetics Corp (HAE)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-07-22 | Nutter Brad (President & CEO) | Sale | 50,000 | 55.00 | 2,750,000 |
| 2008-07-22 | Nutter Brad (President & CEO) | Option Exercise | 50,000 | 21.91 | 1,095,500 |
| 2008-06-30 | Pare Anthony (Other) | Sale | 500 | 57.40 | 28,700 |
| 2008-06-30 | Pare Anthony (Other) | Option Exercise | 500 | 26.10 | 13,052 |
| 2008-06-16 | Nutter Brad (President & CEO) | Sale | 50,000 | 57.13 | 2,856,330 |
| 2008-06-16 | Nutter Brad (President & CEO) | Option Exercise | 50,000 | 21.91 | 1,095,500 |
| 2008-05-16 | Concannon Brian (Chief Operating Officer) | Sale | 775 | 55.44 | 42,966 |
| 2008-05-16 | Nutter Brad (President & CEO) | Sale | 50,000 | 55.05 | 2,752,620 |
| 2008-05-16 | Nutter Brad (President & CEO) | Option Exercise | 50,000 | 21.91 | 1,095,500 |
| 2008-05-05 | Granadillo Pedro P (Director) | Purchase | 1,800 | 53.59 | 96,462 |
| 2008-05-01 | Pare Anthony (Other) | Purchase | 231 | 44.35 | 10,245 |
| 2008-05-01 | O'shaughnessy James (Other) | Purchase | 440 | 44.35 | 19,515 |
| 2008-05-01 | Conneely Jan (VP & GM, Arryx, Inc.) | Purchase | 304 | 44.35 | 13,483 |
| 2008-05-01 | Hattori Keiko (President, Haemonetics Japan) | Purchase | 126 | 44.35 | 5,588 |
| 2008-05-01 | Granville William (VP, Manufacturing) | Purchase | 411 | 44.35 | 18,229 |
| 2008-05-01 | Popovsky Mark A (VP, Corporate Medical Director) | Purchase | 246 | 44.35 | 10,910 |
| 2008-05-01 | Lindop Christopher J (VP, Finance & CFO) | Purchase | 260 | 44.35 | 11,531 |
| 2008-05-01 | Allen Peter M (President, Donor Division) | Purchase | 297 | 44.35 | 13,172 |
| 2008-05-01 | Concannon Brian (President, Patient Division) | Purchase | 479 | 44.35 | 21,245 |
| 2008-05-01 | Lopez Alicia R (VP, General Counsel) | Purchase | 328 | 44.35 | 14,547 |
| 2008-05-01 | Swenson Stephen (VP & General Mgr, Global Plasm) | Purchase | 238 | 44.35 | 10,556 |
| 2008-05-01 | Ebbeling Robert B (Vice President, Operations) | Purchase | 479 | 44.35 | 21,245 |
| 2008-05-01 | Hanlon Susan M (VP, Planning and Control) | Purchase | 138 | 44.35 | 6,120 |
| 2008-05-01 | Beucler Mark (Other) | Purchase | 422 | 44.35 | 18,716 |
| 2008-04-21 | Pare Anthony (Other) | Sale | 500 | 55.98 | 27,990 |
| 2008-04-21 | Pare Anthony (Other) | Option Exercise | 500 | 26.10 | 13,052 |
| 2008-03-13 | Swenson Stephen (VP & General Mgr, Global Plasm) | Sale | 400 | 58.87 | 23,549 |
| 2008-03-13 | Swenson Stephen (VP & General Mgr, Global Plasm) | Option Exercise | 400 | 26.10 | 10,442 |
| 2008-03-12 | Swenson Stephen (VP & General Mgr, Global Plasm) | Sale | 223 | 58.43 | 13,029 |
| 2008-02-28 | Lopez Alicia R (VP, General Counsel) | Sale | 9,500 | 58.70 | 557,674 |
| 2008-02-28 | Lopez Alicia R (VP, General Counsel) | Option Exercise | 9,500 | 17.62 | 167,437 |
| 2008-01-02 | Popovsky Mark A (VP, Corporate Medical Director) | Sale | 10,000 | 61.98 | 619,800 |
| 2008-01-02 | Popovsky Mark A (VP, Corporate Medical Director) | Option Exercise | 10,000 | 28.88 | 288,825 |
| 2007-11-28 | Lawlor Thomas (President, Patient Division) | Sale | 12,500 | 57.56 | 719,440 |
| 2007-11-28 | Lawlor Thomas (President, Patient Division) | Option Exercise | 12,500 | 47.51 | 593,875 |
| 2007-11-06 | Allen Peter M (President, Donor Division) | Sale | 6,350 | 57.44 | 364,731 |
| 2007-11-06 | Allen Peter M (President, Donor Division) | Option Exercise | 6,350 | 21.46 | 136,271 |
| 2007-11-01 | Popovsky Mark A (VP, Corporate Medical Director) | Purchase | 253 | 40.66 | 10,287 |
| 2007-11-01 | Lindop Christopher J (VP, Finance & CFO) | Purchase | 284 | 40.66 | 11,548 |
| 2007-11-01 | Allen Peter M (President, Donor Division) | Purchase | 197 | 40.66 | 8,010 |
| 2007-11-01 | Lopez Alicia R (VP, General Counsel) | Purchase | 182 | 40.66 | 7,400 |
| 2007-11-01 | Ebbeling Robert B (Vice President, Operations) | Purchase | 144 | 40.66 | 5,855 |
| 2007-11-01 | Hanlon Susan M (VP, Planning and Control) | Purchase | 139 | 40.66 | 5,652 |
| 2007-07-02 | Popovsky Mark A (VP, Corporate Medical Director) | Sale | 7,000 | 52.79 | 369,504 |
| 2007-07-02 | Popovsky Mark A (VP, Corporate Medical Director) | Option Exercise | 7,000 | 22.72 | 159,031 |
| 2007-06-14 | Sakai Ryoji (President, Japan) | Sale | 8,000 | 51.00 | 408,000 |
| 2007-06-14 | Sakai Ryoji (President, Japan) | Option Exercise | 8,000 | 31.66 | 253,280 |
| 2007-05-04 | Still William Roche (VP & Gen Mrg, Therapeutics Bus) | Sale | 10,000 | 50.07 | 500,733 |
| 2007-05-04 | Still William Roche (VP & Gen Mrg, Therapeutics Bus) | Option Exercise | 10,000 | 24.24 | 242,350 |
| 2007-05-01 | Popovsky Mark A (VP, Corporate Medical Director) | Purchase | 282 | 38.63 | 10,894 |
| 2007-05-01 | Still William Roche (VP & Gen Mrg, Therapeutics Bus) | Purchase | 344 | 38.63 | 13,289 |
| 2007-05-01 | Allen Peter M (President, Donor Division) | Purchase | 341 | 38.63 | 13,173 |
| 2007-05-01 | Forish Joseph J (VP, Human Resources) | Purchase | 1,100 | 38.63 | 42,494 |
| 2007-05-01 | Lopez Alicia R (VP, General Counsel) | Purchase | 357 | 38.63 | 13,791 |
| 2007-05-01 | Lopez Alicia R (VP, General Counsel) | Sale | 452 | 47.84 | 21,624 |
| 2007-05-01 | Ebbeling Robert B (Vice President, Operations) | Purchase | 397 | 38.63 | 15,337 |
| 2007-05-01 | Hanlon Susan M (VP, Planning and Control) | Purchase | 146 | 38.63 | 5,640 |
| 2007-04-25 | Popovsky Mark A (VP, Corporate Medical Director) | Sale | 7,000 | 48.00 | 336,000 |
| 2007-04-25 | Popovsky Mark A (VP, Corporate Medical Director) | Option Exercise | 7,000 | 22.72 | 159,031 |
| 2007-02-28 | Lopez Alicia R (VP, General Counsel) | Sale | 5,883 | 44.75 | 263,264 |
| 2007-02-28 | Lopez Alicia R (VP, General Counsel) | Option Exercise | 5,883 | 17.44 | 102,584 |
| 2007-02-13 | Ebbeling Robert B (Vice President, Operations) | Sale | 12,300 | 47.02 | 578,341 |
| 2007-02-13 | Ebbeling Robert B (Vice President, Operations) | Option Exercise | 12,300 | 17.00 | 209,100 |
| 2007-02-02 | Popovsky Mark A (VP, Corporate Medical Director) | Sale | 10,000 | 47.79 | 477,900 |
| 2007-02-02 | Popovsky Mark A (VP, Corporate Medical Director) | Option Exercise | 10,000 | 22.72 | 227,188 |
| 2007-02-02 | Still William Roche (VP & Gen Mrg, Therapeutics Bus) | Sale | 10,000 | 47.78 | 477,840 |
| 2007-02-02 | Still William Roche (VP & Gen Mrg, Therapeutics Bus) | Option Exercise | 10,000 | 24.24 | 242,350 |
| 2006-11-01 | Popovsky Mark A (VP, Corporate Medical Director) | Purchase | 228 | 38.76 | 8,837 |
| 2006-11-01 | Still William Roche (VP & Gen Mrg, Therapeutics Bus) | Purchase | 180 | 38.76 | 6,976 |
| 2006-11-01 | Allen Peter M (President, Donor Division) | Purchase | 181 | 38.76 | 7,015 |
| 2006-11-01 | Eckert Ulrich (President, Europe & Latin Am) | Purchase | 159 | 38.76 | 6,162 |
| 2006-11-01 | Forish Joseph J (VP, Human Resources) | Purchase | 460 | 38.76 | 17,829 |
| 2006-11-01 | Lopez Alicia R (VP, General Counsel) | Purchase | 119 | 38.76 | 4,612 |
| 2006-11-01 | Lopez Alicia R (VP, General Counsel) | Sale | 400 | 45.77 | 18,307 |
| 2006-11-01 | Ryan Ronald J (VP and CFO) | Purchase | 173 | 38.76 | 6,705 |
| 2006-11-01 | Ebbeling Robert B (Vice President, Operations) | Purchase | 184 | 38.76 | 7,131 |
| 2006-11-01 | Hanlon Susan M (VP, Planning and Control) | Purchase | 140 | 38.76 | 5,426 |
| 2006-09-07 | Ryan Ronald J (VP and CFO) | Sale | 59,694 | 45.48 | 2,715,163 |
| 2006-09-07 | Ryan Ronald J (VP and CFO) | Option Exercise | 59,694 | 28.46 | 1,698,612 |
| 2006-08-22 | Corlin Remi (President, Asia) | Sale | 2,500 | 47.39 | 118,475 |
| 2006-08-22 | Corlin Remi (President, Asia) | Option Exercise | 2,500 | 15.88 | 39,687 |
| 2006-08-10 | Ryan Ronald J (VP and CFO) | Sale | 93,016 | 45.00 | 4,185,720 |
| 2006-08-10 | Ryan Ronald J (VP and CFO) | Option Exercise | 93,016 | 15.88 | 1,476,628 |
| 2006-08-02 | Ryan Ronald J (VP and CFO) | Sale | 50,000 | 45.00 | 2,250,000 |
| 2006-08-02 | Ryan Ronald J (VP and CFO) | Option Exercise | 50,000 | 17.73 | 886,720 |
| 2006-08-02 | Gelbman Ronald G (Director) | Purchase | 4,442 | 45.00 | 199,867 |
| 2006-07-03 | Lopez Alicia R (VP, General Counsel) | Sale | 400 | 46.70 | 18,682 |
| 2006-06-27 | Ryan Ronald J (VP and CFO) | Sale | 50,000 | 47.21 | 2,360,495 |
| 2006-06-27 | Ryan Ronald J (VP and CFO) | Option Exercise | 50,000 | 16.06 | 803,125 |
| 2006-06-23 | Eckert Ulrich (President, Europe & Latin Am) | Sale | 5,000 | 49.45 | 247,250 |
| 2006-06-23 | Eckert Ulrich (President, Europe & Latin Am) | Option Exercise | 5,000 | 15.88 | 79,375 |
| 2006-06-22 | Eckert Ulrich (President, Europe & Latin Am) | Sale | 8,000 | 48.07 | 384,560 |
| 2006-06-22 | Eckert Ulrich (President, Europe & Latin Am) | Option Exercise | 8,000 | 16.08 | 128,625 |
| 2006-06-12 | Eckert Ulrich (President, Europe & Latin Am) | Sale | 1,000 | 46.94 | 46,940 |
| 2006-05-01 | Popovsky Mark A (Vp, Corporate Medical Director) | Purchase | 258 | 41.52 | 10,712 |
| 2006-05-01 | Still William Roche (VP & Gen Mrg, Therapeutics Bus) | Purchase | 311 | 41.52 | 12,913 |
| 2006-05-01 | Allen Peter M (President, Donor Division) | Purchase | 310 | 41.52 | 12,871 |
| 2006-05-01 | Concannon Brian (President, Patient Division) | Purchase | 511 | 41.52 | 21,217 |
| 2006-05-01 | Lopez Alicia R (VP, General Counsel) | Purchase | 379 | 41.52 | 15,737 |
| 2006-05-01 | Ryan Ronald J (VP and CFO) | Purchase | 158 | 41.52 | 6,560 |
| 2006-05-01 | Ebbeling Robert B (Vice President, Operations) | Purchase | 307 | 41.52 | 12,747 |
| 2006-05-01 | Hanlon Susan M (VP, Planning and Control) | Purchase | 113 | 41.52 | 4,692 |
| 2006-03-24 | Lopez Alicia R (VP, General Counsel) | Option Exercise | 24,200 | 18.00 | 435,600 |
| 2006-03-21 | Eckert Ulrich (President, Europe & Latin Am) | Option Exercise | 4,000 | 18.00 | 72,000 |
| 2006-02-02 | Popovsky Mark A (Vp, Corporate Medica) | Sale | 7,000 | 50.20 | 351,400 |
| 2006-02-02 | Popovsky Mark A (Vp, Corporate Medica) | Option Exercise | 7,000 | 22.72 | 159,033 |
| 2006-02-02 | Still William Roche (Bus. Dev.) | Purchase | 2,110 | 49.75 | 104,972 |
| 2005-11-22 | Foote Susan Bartlett (Director) | Purchase | 2,000 | 49.25 | 98,492 |
| 2005-11-02 | Granadillo Pedro P (Director) | Purchase | 3,000 | 48.86 | 146,589 |
| 2005-11-01 | Allen Peter M (President, Donor Div) | Purchase | 203 | 35.88 | 7,283 |
| 2005-09-02 | Granadillo Pedro P (Director) | Purchase | 1,000 | 44.71 | 44,710 |
| 2005-05-02 | Popovsky Mark A (Vp, Corporate Medica) | Purchase | 441 | 27.20 | 11,995 |
| 2005-05-02 | Still William Roche (Bus. Dev.) | Purchase | 422 | .20 | 84 |
| 2005-05-02 | Allen Peter M (President, Donor Div) | Purchase | 262 | 27.20 | 7,126 |
| 2005-05-02 | Concannon Brian (President, Patient D) | Purchase | 800 | 27.20 | 21,760 |
| 2005-05-02 | Lopez Alicia R (VP, Administ) | Purchase | 472 | 27.20 | 12,838 |
| 2005-05-02 | Sakurada Yutaka (Asia) | Purchase | 63 | 27.20 | 1,713 |
| 2005-05-02 | Ryan Ronald J (CFO) | Purchase | 236 | 27.20 | 6,419 |
| 2005-05-02 | Ebbeling Robert B (Vice President, Oper) | Purchase | 428 | 27.20 | 11,641 |
| 2005-05-02 | Hanlon Susan M (V.P Planning and Con) | Purchase | 166 | 27.20 | 4,515 |
| 2005-04-15 | Lopez Alicia R (VP, Administ) | Sale | 400 | 77.00 | 30,800 |
| 2004-04-15 | Lopez Alicia R (VP, Administ) | Sale | 400 | 29.55 | 11,820 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Haemonetics Corp (symbol HAE,
CIK number 313143) see
the Securities and Exchange Commission (SEC) website.
|
|
